Case studies show some patients with LVV can achieve remission after treatment with biological agents
Giant Cell Arteritis Challenging to Diagnose, Manage
Common form of primary vasculitis difficult to identify, treat, but latest research suggests potential new therapeutic targets
Diagnose, Manage and Treat Giant Cell Arteritis
A rheumatologist at the California Rheumatology Alliance 10th Annual Medical & Scientific Meeting in San Francisco shares research findings on this inflammatory blood vessel disease
Fellow’s Forum Case Report: Takayasu’s Arteritis
How this rare form of large-vessel vasculitis affects different portions, branches of aorta and ways to diagnose, treat and manage the disease
Research Into Causes of Systemic Vasculitis May Lead to Targeted Treatments Say Rheumatologists at the 2013 ACR/ARHP Annual Meeting
Studies focused on role of the immune system in disease development, and contributing genetic and environmental factors, may elicit better therapeutic approaches to small- and large-vessel vasculitis
How Rheumatism Got its Name
The origination of the ailing word and its variations throughout history used to describe rheumatic disorders
Letters: More on the History of Polymyalgia Rheumatica and Giant Cell Arteritis
These syndromes were completely ignored in U.S. literature for years
A&R Abstracts: CNS Vasculitis
For Further Reading
Giant Cell Arteritis
Giant cell arteritis (GCA)—a type of vasculitis—is a group of diseases whose typical feature is inflammation of blood vessels. The blood vessels most commonly involved are the arteries of the scalp and head (especially the arteries over the temples), which is why another term for GCA is “temporal arteritis.” GCA can overlap with another rheumatic disease called polymyalgia rheumatica, and symptoms of the two conditions can occur at the same time or separately. The causes of GCA and polymyalgia rheumatica are unknown.
The Symptoms or the Disease
Where should we focus?